Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Toyonaga

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Frontiers in Neurology|February 27, 2023
Decreased synaptic vesicle glycoprotein 2A binding in a rodent model of familial Alzheimer's disease detected by [<sup>18</sup>F]SDM-16Chao Zheng, Takuya Toyonaga, Baosheng Chen, et al.
Machine Learning in Clinical Neuroimaging : 6Th International Workshop, MLCN 2023, Held in Conjunction with MICCAI 2023, Vancouver, BC, Canada, October 8, 2023, Proceedings. MLCN (Workshop) (6Th : 2023 : Vancouver, B.C.)|January 4, 2024
Cross-Attention for Improved Motion Correction in Brain PETZhuotong Cai, Tianyi Zeng, Eléonore V Lieffrig, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2016
(18)F-fluoromisonidazole positron emission tomography can predict pathological necrosis of brain tumorsTakuya Toyonaga, Kenji Hirata, Shigeru Yamaguchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 25, 2017
Scatter Correction with Combined Single-Scatter Simulation and Monte Carlo Simulation Scaling Improved the Visual Artifacts and Quantification in 3-Dimensional Brain PET/CT Imaging with <sup>15</sup>O-Gas InhalationKeiichi Magota, Tohru Shiga, Yukari Asano, et al.
Molecular Psychiatry|June 17, 2021
In vivo evidence of lower synaptic vesicle density in schizophreniaRajiv Radhakrishnan, Patrick D Skosnik, Mohini Ranganathan, et al.
EJNMMI Research|July 7, 2019
Biodistribution and radiation dosimetry of the novel hypoxia PET probe [<sup>18</sup>F]DiFA and comparison with [<sup>18</sup>F]FMISOShiro Watanabe, Tohru Shiga, Kenji Hirata, et al.
EJNMMI Research|December 6, 2019
Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapyShiro Watanabe, Tetsuya Inoue, Shozo Okamoto, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 19, 2019
In Vivo Synaptic Density Imaging with <sup>11</sup>C-UCB-J Detects Treatment Effects of Saracatinib in a Mouse Model of Alzheimer DiseaseTakuya Toyonaga, Levi M Smith, Sjoerd J Finnema, et al.
Molecular Psychiatry|August 2, 2025
PET imaging evidence of HDAC6 suppression in the amygdala across species in PTSDRobin E Bonomi, Mika Naganawa, Delaney McRiley, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2016
Hypoxic glucose metabolism in glioblastoma as a potential prognostic factorTakuya Toyonaga, Shigeru Yamaguchi, Kenji Hirata, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Frontiers in Neurology|February 27, 2023
Decreased synaptic vesicle glycoprotein 2A binding in a rodent model of familial Alzheimer's disease detected by [<sup>18</sup>F]SDM-16Chao Zheng, Takuya Toyonaga, Baosheng Chen, et al.
Machine Learning in Clinical Neuroimaging : 6Th International Workshop, MLCN 2023, Held in Conjunction with MICCAI 2023, Vancouver, BC, Canada, October 8, 2023, Proceedings. MLCN (Workshop) (6Th : 2023 : Vancouver, B.C.)|January 4, 2024
Cross-Attention for Improved Motion Correction in Brain PETZhuotong Cai, Tianyi Zeng, Eléonore V Lieffrig, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2016
(18)F-fluoromisonidazole positron emission tomography can predict pathological necrosis of brain tumorsTakuya Toyonaga, Kenji Hirata, Shigeru Yamaguchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 25, 2017
Scatter Correction with Combined Single-Scatter Simulation and Monte Carlo Simulation Scaling Improved the Visual Artifacts and Quantification in 3-Dimensional Brain PET/CT Imaging with <sup>15</sup>O-Gas InhalationKeiichi Magota, Tohru Shiga, Yukari Asano, et al.
Molecular Psychiatry|June 17, 2021
In vivo evidence of lower synaptic vesicle density in schizophreniaRajiv Radhakrishnan, Patrick D Skosnik, Mohini Ranganathan, et al.
EJNMMI Research|July 7, 2019
Biodistribution and radiation dosimetry of the novel hypoxia PET probe [<sup>18</sup>F]DiFA and comparison with [<sup>18</sup>F]FMISOShiro Watanabe, Tohru Shiga, Kenji Hirata, et al.
EJNMMI Research|December 6, 2019
Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapyShiro Watanabe, Tetsuya Inoue, Shozo Okamoto, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 19, 2019
In Vivo Synaptic Density Imaging with <sup>11</sup>C-UCB-J Detects Treatment Effects of Saracatinib in a Mouse Model of Alzheimer DiseaseTakuya Toyonaga, Levi M Smith, Sjoerd J Finnema, et al.
Molecular Psychiatry|August 2, 2025
PET imaging evidence of HDAC6 suppression in the amygdala across species in PTSDRobin E Bonomi, Mika Naganawa, Delaney McRiley, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2016
Hypoxic glucose metabolism in glioblastoma as a potential prognostic factorTakuya Toyonaga, Shigeru Yamaguchi, Kenji Hirata, et al.
Pageof 10